The Perth node of the CRC was launched on 24th November 2011 by His Excellency Mr Malcolm McCusker QC AO at the McCusker Alzheimers Research Foundation in Nedlands.
The CRC will undertake research to identify and confirm biomarkers for the early detection and treatment of Alzheimer's and Parkinson's disease (the neurodegenerative disorders) as well as Schizophrenia and depression (the psychoses), under investigation in its programs.
These biomarkers could range from specific cells, proteins, genes or gene products through to hormones; or be subtle brain image changes detected through MRI or PET scanning.
Once confirmed, these biomarkers will greatly enhance the opportunities for:
Very important work will then be undertaken with the relevant health care professionals involved in the CRC ensuring that these discoveries and new approaches to treatment are translated into practical approaches and integrated into modern medical and health care practices.
This CRC research will therefore enable early intervention in particular mental health disorders, helping delay the onset of these conditions, and also potentially reducing the severity of disease, by helping deliver more effective treatments.
The willingness of researchers from diverse streams of science to come together, sharing their knowledge and expertise, to tackle these mental health conditions, is a testament to their dedication and commitment to a better world through scientific excellence.